KLHL3-Cab39 Disruption Drives WNK4-Independent Hyperkalemic Hypertension
Shih-Hua Lin, Ying-Chuan Chen, Yi-Xuan Ding, Chih-Jen Cheng, Pei-Yao Liu, Yu-Lung Lin, Jhao-Jhuang Ding, Chih-Chien Sung, Sung-Sen Yang, Hwei-Jen Lee, Chien-Ming LinBACKGROUND:
Familial hyperkalemic hypertension, also known as pseudohypoaldosteronism type II (PHAII), is characterized by hypertension and hyperkalemic metabolic acidosis and involves dysregulation of the KLHL3 (Kelch-like 3)-cullin3 E3 ubiquitin ligase complex, affecting WNK1/4 (with-no-lysine kinase 1/4)-mediated SPAK (Ste20-related proline/alanine-rich kinase)/OSR1 (oxidative stress response kinase 1)-NCC (Na + -Cl − cotransporter) signaling. How KLHL3 phosphorylation mutations modulate this pathway remains poorly defined.
METHODS:
We generated knock-in mouse models expressing phosphomimetic (
RESULTS:
Both knock-in strains exhibited typical PHAII features despite unchanged KLHL3 levels, with enhanced SPAK/OSR1-NCC phosphorylation, increased Cab39 levels, and unchanged WNK1/4 expression. Under high-salt loading,
CONCLUSIONS:
These findings indicate that the integrity of Ser486 itself, rather than its phosphorylation state, is required for KLHL3-mediated Cab39 ubiquitination and define a WNK4-independent PHAII mechanism driven by impaired Cab39 degradation and consequent SPAK/OSR1-Na+-Cl− cotransporter activation.